Literature DB >> 9062358

Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves.

S S Srivatsa1, P J Harrity, P B Maercklein, L Kleppe, J Veinot, W D Edwards, C M Johnson, L A Fitzpatrick.   

Abstract

Dystrophic mineralization remains the leading cause of stenotic or regurgitant failure in native human and porcine bioprosthetic heart valves. We hypothesized that cellular expression of noncollagenous matrix proteins (osteopontin, osteocalcin, and osteonectin) that regulate skeletal mineralization may orchestrate valvular calcification. Porcine bioprosthetic heart valves and native human heart valves obtained during replacement surgery were analyzed for cells, matrix proteins that regulate mineralization, and vessels. Cell accumulation and calcification were correlated for both valve types (rho = 0.75, P = 0.01, native; rho = 0.42, P = 0.08, bioprosthetic). Osteopontin expression correlated with cell accumulation (rho = 0.58, P = 0.04) and calcification (rho = 0.52, P = 0.06) for bioprosthetic valves. Osteocalcin expression correlated with calcification (rho = 0.77, P = 0.04) and cell accumulation (rho = 0.69, P = 0.07) in native valves. Comparisons of calcified versus noncalcified native and bioprosthetic valves for averaged total matrix protein mRNA signal score revealed increased noncollagenous proteins mRNA levels in calcified valves (P = 0.07, group I vs. group II; P = 0.02, group III vs. group IV). When stratified according to positive versus negative mRNA signal status, both calcified bioprosthetic valves (P = 0.03) and calcified native valves (P = 0.01) were significantly more positive for noncollagenous proteins mRNA than their noncalcified counterparts. Local cell-associated expression of proteins regulating mineralization suggests a highly coordinated mechanism of bioprosthetic and native valve calcification analogous to physiologic bone mineralization. Modulation of cellular infiltration or cellular expression of matrix proteins that regulate mineralization, may offer an effective therapeutic approach to the prevention of valve failure secondary to calcification.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062358      PMCID: PMC507908          DOI: 10.1172/JCI119265

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

1.  Immunogenicity of glutaraldehyde-tanned bovine pericardium.

Authors:  M Dahm; W D Lyman; A B Schwell; S M Factor; R W Frater
Journal:  J Thorac Cardiovasc Surg       Date:  1990-06       Impact factor: 5.209

2.  Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro.

Authors:  L Liaw; M Almeida; C E Hart; S M Schwartz; C M Giachelli
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

3.  Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption.

Authors:  F P Ross; J Chappel; J I Alvarez; D Sander; W T Butler; M C Farach-Carson; K A Mintz; P G Robey; S L Teitelbaum; D A Cheresh
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

4.  Effects of fixation and demineralization on the retention of bone phosphoprotein and other matrix components as evaluated by biochemical analyses and quantitative immunocytochemistry.

Authors:  M D McKee; A Nanci; W J Landis; Y Gotoh; L C Gerstenfeld; M J Glimcher
Journal:  J Bone Miner Res       Date:  1991-09       Impact factor: 6.741

5.  Bone morphogenetic protein expression in human atherosclerotic lesions.

Authors:  K Boström; K E Watson; S Horn; C Wortham; I M Herman; L L Demer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro.

Authors:  A P Gadeau; M Campan; D Millet; T Candresse; C Desgranges
Journal:  Arterioscler Thromb       Date:  1993-01

7.  The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors.

Authors:  E W Raines; T F Lane; M L Iruela-Arispe; R Ross; E H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

Review 8.  Degenerative aortic stenosis. One effect of the graying of America.

Authors:  J H O'Keefe; C J Lavie; R A Nishimura; W D Edwards
Journal:  Postgrad Med       Date:  1991-02-01       Impact factor: 3.840

Review 9.  Cardiac valve prostheses: pathological and bioengineering considerations.

Authors:  F J Schoen
Journal:  J Card Surg       Date:  1987-03       Impact factor: 1.620

10.  SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway.

Authors:  P M Tremble; T F Lane; E H Sage; Z Werb
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

View more
  30 in total

Review 1.  Ectopic calcification: gathering hard facts about soft tissue mineralization.

Authors:  C M Giachelli
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.

Authors:  Susan A Steitz; Mei Y Speer; Marc D McKee; Lucy Liaw; Manuela Almeida; Hsueh Yang; Cecilia M Giachelli
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice.

Authors:  Masahito Hirose; Keiichi Tozawa; Atsushi Okada; Shuzo Hamamoto; Yuji Higashibata; Bin Gao; Yutaro Hayashi; Hideo Shimizu; Yasue Kubota; Takahiro Yasui; Kenjiro Kohri
Journal:  Urol Res       Date:  2011-08-11

Review 4.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

5.  Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis.

Authors:  B Jian; P L Jones; Q Li; E R Mohler; F J Schoen; R J Levy
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 6.  The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology.

Authors:  Amber C Liu; Vineet R Joag; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

7.  Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo.

Authors:  C M Giachelli; D Lombardi; R J Johnson; C E Murry; M Almeida
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

8.  Regulation of valvular interstitial cell calcification by components of the extracellular matrix.

Authors:  Karien J Rodriguez; Kristyn S Masters
Journal:  J Biomed Mater Res A       Date:  2009-09-15       Impact factor: 4.396

9.  Genetic variation and atherosclerosis.

Authors:  Erik Biros; Mirko Karan; Jonathan Golledge
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

10.  Valvular aortic stenosis: a proteomic insight.

Authors:  Felix Gil-Dones; Tatiana Martin-Rojas; Luis F Lopez-Almodovar; Fernando de la Cuesta; Veronica M Darde; Gloria Alvarez-Llamas; Rocio Juarez-Tosina; Gemma Barroso; Fernando Vivanco; Luis R Padial; Maria G Barderas
Journal:  Clin Med Insights Cardiol       Date:  2010-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.